The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 IMS Health Inc.  (RX) Trade Now »     Rate RX  -  Discuss RX  -  Add to Watch List         Graphic_subscribe

  
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate RX:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

RX: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

A Global Small & Mid-Cap Health IT Index Graphic_rating_buy RX
Mikerun
73%
 +70.65%
in 360 days

A Global Small & Mid-Cap Health IT Index

<>
<> The accompanying table presents statistics and the top five rated companies in the ETFI Global Health Information Technology [IT] Index, which is structured to include companies with market caps between $100M - $10B with the following business operations:

1.) electronic transmission, storage, and processing of prescriptions – such as Allscripts-Misys Healthcare Solutions (MDRX)

2.) secure e-mail transmission for healthcare facilities – such as Zix Corp (ZIXI)

3.) electronic storage and systems for...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/14/08 Comment




From the Blogosphere

Big Pharma and Biotech – Industry Outlook
Logo1
38%

The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent losses.

According to IMS Health (RX), this is the main reason why global pharmaceutical market growth will be restricted to the mid-single digits through 2013. Over the next five years, products that currently generate about $137 billion in sales are expected to face generic co...
By  StraightStocks   (-8.01%  risk: moderate)  11/09/09 Comment


KKR guns for a military deal -- buys Northrop Grumman's TASC

Filed under: Deals, Private equity, Northrop Grumman (NOC)

Could it be that private-equity buyouts are making a comeback? There are certainly signs of a return. Just last week, TPG and the Canada Pension Plan agreed to shell out $4 billion for IMS Health (RX).

This week, we have another interesting deal: KKR and General Atlantic will buy TASC for $1.65 billion. TASC is the consulting unit of Northrop Grumman (NOC).

Actually, the military giant had little choice but to unload the division because of a conflict of interest. How can you provide unbiased consulting to the U.S. government as wel...
By  Tom Taulli   (+0.00%)  11/09/09 Comment


Unusual 11 Mid-Day Movers 11/05: RX, FSYS, NWK, ROYL Higher; SMSI, ELMG, PL, CVS Lower
Smith Micro Software (NASDAQ: SMSI) <font>26.7% LOWER;</font> reports Q3 adjusted EPS of $0.20, 1 cent better than the analyst estimate of $0.19. Revenue for the quarter was $27.80 million, which compares to the estimate of $29.37 million. Lowers FY09 Guidance from $110 - $115 million to $105 - $110 million, versus $111.30 million consensus.IMS Health (NYSE: RX) <font>23.6% HIGHER;</font> entered into a definitive agreement to be acquired by investment funds managed by TPG Capital and the CPP Investment Board in a transaction with a total value of $5.2 billion, including the assumption of d...
By  Street Insider   (+19.84%  risk: moderate)  11/05/09 Comment


IMS is buyout bait?

Filed under: Private equity

Activity continues to buzz in the private equity world. For example, according to the Wall Street Journal (subscription required), it appears that IMS (NYSE: RX) is in advanced talks to take the company private. As a result, the shares of the company soared 22% in Monday's trading.

No doubt, a deal could fall apart. But, the fact remains that IMS has definitely attracted interest. Some of the suitors include: TPG, Silver Lake, and BC Partners. The deal could be worth as much as $3.5 billion.

<>IMS got its start in the mid 1950s when the founders -- Bill Frohlich (an a...
By  Tom Taulli   (+0.00%)  10/20/09 Comment


Is IMS Health a Good Investment?

Below is our investment analysis for IMS Health (RX).

Executive Summary

<>
  • Attractive and sustainable return on invested capital
  • Exceeded 100% over the past ten years
  • High customer switching costs should help sustain returns on invested capital over a long time period
  • Management team focused on delivering value to shareholders
  • CEO has meaningful equity ownership in t he company
  • The company has consistently delivered excess cash flow back to shareholders through dividends, stock buybacks, and paying down debt
  • Attractive valuation
    • <><><><>Current stock price implies a...
    By  trackseekingalpha   (-13.57%  risk: aggressive)  08/20/09 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.56% 369
    2 Gerald Greene 18.14 +69.43% 206
    3 stockmarketfunding.com 17.66 +25.71% 53
    4 akiralegrand 13.47 +14.32% 61
    5 anup2104 12.13 +75.75% 34


    POPULAR STOCKS
    Symbol Company Name Sentiment
    V Visa Inc
    GLD streetTRACKS Gold
    SIRI Sirius Satellite Radio Inc
    GS Goldman Sachs Group Inc The
    AMD Advanced Micro Devices Inc
    KO The CocaCola Company

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on RX

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About IMS Health Inc. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch